Li CY - Search Results

1

Thalidomide treatment in myelofibrosis with myeloid metaplasia.

Elliott MA, Mesa RA, Li CY, Hook CC, Ansell SM, Levitt RM, Geyer SM, Tefferi A. Elliott MA, et al. Among authors: li cy. Br J Haematol. 2002 May;117(2):288-96. doi: 10.1046/j.1365-2141.2002.03443.x. Br J Haematol. 2002. PMID: 11972510 Free article. Clinical Trial.

2

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.

Steensma DP, Mesa RA, Li CY, Gray L, Tefferi A. Steensma DP, et al. Among authors: li cy. Blood. 2002 Mar 15;99(6):2252-4. doi: 10.1182/blood.v99.6.2252. Blood. 2002. PMID: 11877307 Free article. Clinical Trial.

3

Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.

Elliot MA, Yoon SY, Kao P, Li CY, Tefferi A. Elliot MA, et al. Among authors: li cy. Eur J Haematol. 2002 Mar;68(3):175-9. doi: 10.1034/j.1600-0609.2002.01534.x. Eur J Haematol. 2002. PMID: 12068799

4

A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia.

Mesa RA, Steensma DP, Pardanani A, Li CY, Elliott M, Kaufmann SH, Wiseman G, Gray LA, Schroeder G, Reeder T, Zeldis JB, Tefferi A. Mesa RA, et al. Among authors: li cy. Blood. 2003 Apr 1;101(7):2534-41. doi: 10.1182/blood-2002-09-2928. Epub 2002 Nov 27. Blood. 2003. PMID: 12517815 Free article. Clinical Trial.

5

Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment.

Koch CA, Li CY, Mesa RA, Tefferi A. Koch CA, et al. Among authors: li cy. Mayo Clin Proc. 2003 Oct;78(10):1223-33. doi: 10.4065/78.10.1223. Mayo Clin Proc. 2003. PMID: 14531481

6

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.

Mesa RA, Li CY, Ketterling RP, Schroeder GS, Knudson RA, Tefferi A. Mesa RA, et al. Among authors: li cy. Blood. 2005 Feb 1;105(3):973-7. doi: 10.1182/blood-2004-07-2864. Epub 2004 Sep 23. Blood. 2005. PMID: 15388582 Free article.

7

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates.

Tefferi A, Lasho TL, Schwager SM, Steensma DP, Mesa RA, Li CY, Wadleigh M, Gary Gilliland D. Tefferi A, et al. Among authors: li cy. Br J Haematol. 2005 Nov;131(3):320-8. doi: 10.1111/j.1365-2141.2005.05776.x. Br J Haematol. 2005. PMID: 16225651 Free article.

8

Microcytosis in agnogenic myeloid metaplasia: prevalence and clinical correlates.

Tefferi A, Dingli D, Li CY, Mesa RA. Tefferi A, et al. Among authors: li cy. Leuk Res. 2006 Jun;30(6):677-80. doi: 10.1016/j.leukres.2005.10.006. Epub 2005 Nov 8. Leuk Res. 2006. PMID: 16288807

9

Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapy.

Tefferi A, Strand JJ, Lasho TL, Elliott MA, Li CY, Mesa RA, Dewald GW. Tefferi A, et al. Among authors: li cy. Cancer. 2006 Apr 15;106(8):1739-43. doi: 10.1002/cncr.21787. Cancer. 2006. PMID: 16532437 Free article.

10

Risk factors for leukemic transformation in patients with primary myelofibrosis.

Huang J, Li CY, Mesa RA, Wu W, Hanson CA, Pardanani A, Tefferi A. Huang J, et al. Among authors: li cy. Cancer. 2008 Jun 15;112(12):2726-32. doi: 10.1002/cncr.23505. Cancer. 2008. PMID: 18404742 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,035 results

Search Page

Filters